-
Uncategorized2 months ago
StockWatch: Trump Order Lifts Psychedelic Drug Shares
Stocks of most publicly traded psychedelic drug developers jumped when President Donald Trump signed Executive Order 14401, directing the FDA and other federal agencies to accelerate...
-
Uncategorized2 months agoNancy Cox, a CDC veteran and a stalwart in global flu research, dies at 77
Nancy Cox, who for decades was a global leader in influenza research, has died. Cox headed the influenza team at the Centers for Disease Control and...
-
Uncategorized2 months agoOpinion: The podcast telling the stories behind Ambien, Ozempic, EpiPens, and other game-changing drugs
Below is a lightly edited, AI-generated transcript of the “First Opinion Podcast” interview with Thomas Goetz. Be sure to sign up for the weekly “First Opinion...
-
Uncategorized2 months ago
Sanofi’s immunology reckoning; Lilly acquires in vivo CAR-T biotech; RevMed’s ‘Herceptin moment’; and more
Sanofi’s immunology reckoning; Lilly acquires in vivo CAR-T biotech; RevMed’s ‘Herceptin moment’; and more
-
Uncategorized2 months ago
Thermo Fisher sees higher Q1 earnings amid strong biopharma demand
Thermo Fisher Scientific reported “a strong start to the year,” buoyed by strong demand from its pharma and biotech customers, investment in new technologies and the...
-
Uncategorized2 months ago
Engineered conductive pili enable high-efficiency photosynthetic electron extraction in biophotovoltaics
Post Content
-
Uncategorized2 months agoAI Learns to Predict Breast Cancer Risk from How Single Cells Respond to Pressure
A study headed by researchers at City of Hope and the University of California, Berkeley has found that physical and mechanical properties of normal human mammary...
-
Uncategorized2 months ago
Single-Cell Atlas of the Prenatal Brain Reveals How Down Syndrome Reshapes Development
A cellular-resolution molecular map details how Down syndrome alters human brain development before birth. The study analyzed more than 100,000 nuclei from human prenatal neocortex samples...
-
Uncategorized2 months agoSTAT+: FDA to speed up review of three psychedelics as mental health treatments
The Food and Drug Administration will accelerate its review of psychedelic drugs developed by Compass Pathways, the Usona Institute, and Transcend Therapeutics for mental health disorders,...
-
Uncategorized2 months agoSTAT+: A biotech VC on what Eli Lilly saw in a struggling cancer startup for $3.2B
Kelonia Therapeutics became the newest biotech takeout target this week. The privately held company, which is developing cell therapies for cancer and autoimmune diseases, will be...
STAT+: Pharmalittle: We’re reading about Pfizer’s emergency penicillin program, a Sanofi diabetes drug, and more
